NHS, Red blood cell and CRISPR gene editing

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...
Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...
Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...